That this House welcomes Diabetes UK's Diabetes Week (11th to 15th June) campaign to end the postcode lottery for insulin pump therapy; further welcomes the Diabetes Week message that making a small change through providing the technology can make a big difference to the lives of people with diabetes; notes the National Institute for Health and Clinical Excellence (NICE) recommendation that insulin pump therapy should be available as a treatment option for people with type 1 diabetes in cases where multiple dose insulin therapy has failed, and the person is willing and able to use insulin pump therapy effectively; notes with concern that this guidance is not being adhered to locally in a uniform manner; is aware that currently only two per cent. of people with type 1 diabetes use pumps in the UK, compared to 10 to 20 per cent. in other European member states and around 15 to 20 per cent. in the United States; believes that the use of pumps can have cost benefits to the local NHS through a reduction in primary care contracts, reduction in hospital admissions and hospital outpatient contacts; and calls on the Government to oversee the implementation of NICE guidance by primary care organisations to end the postcode lottery.

That this House welcomes Diabetes UK's Diabetes Week (11th to 15th June) campaign to end the postcode lottery for insulin pump therapy; further welcomes the Diabetes Week message that making a small change through providing the technology can make a big difference to the lives of people with diabetes; notes...

That this House welcomes the launch of the Diabetes and the Fire Service: Survey Report, which investigates recruitment and retention practices with regard to people with diabetes in the Fire Service; notes that since the extension to the Disability Discrimination Act in October 2004 people with diabetes are protected from discrimination in the emergency services; notes that well-controlled diabetes is not a bar to working in hazardous occupations such as the fire service; further notes that individual medical assessment is the best method of ascertaining fitness to work; welcomes the main findings of the report that there is widespread recognition of the need to treat all cases individually; notes with regret that there are still variations in recruitment practice across fire and rescue services; and calls on the Government to promote good practice in order to apply it consistently across the UK.

That this House welcomes the launch of the Diabetes and the Fire Service: Survey Report, which investigates recruitment and retention practices with regard to people with diabetes in the Fire Service; notes that since the extension to the Disability Discrimination Act in October 2004 people with diabetes are protected from...

That this House welcomes the Diabetes UK (Diabetes: State of the Nations) report; notes with concern the findings on structured patient information that only half of adults, and a quarter of children and young people, living with diabetes are aware of any structured education courses to help them manage their condition; also notes with concern that information about the courses that are available is lacking; further notes that a majority of people newly diagnosed with diabetes do not receive structured education in their first year living with the condition; realises that to improve the health of the nation there is a need to improve patient knowledge and provide patient information to enable people with diabetes to be able to make decisions about their lifestyle, care and medication; realises that providing patients with information is a simple way to save lives, improve quality of life and reduce costs to the NHS; and calls on the Government to make best use of and recognise the third sector as leaders in terms of knowledge and expertise in providing relevant and tailored support, information and education to patients.

That this House welcomes the Diabetes UK (Diabetes: State of the Nations) report; notes with concern the findings on structured patient information that only half of adults, and a quarter of children and young people, living with diabetes are aware of any structured education courses to help them manage their...

That this House notes with grave concern the increasing problem of diabetes in the UK and internationally; further notes that in many parts of the developing world, because of lack of available treatment and drugs, diabetes can mean certain death; congratulates Diabetes UK on its support for the campaign for a UN resolution on diabetes which would urge member states to improve care and treatment, to adopt robust policies to prevent type 2 diabetes and to promote research into the condition; and calls on the Government to actively support the proposed resolution.

That this House notes with grave concern the increasing problem of diabetes in the UK and internationally; further notes that in many parts of the developing world, because of lack of available treatment and drugs, diabetes can mean certain death; congratulates Diabetes UK on its support for the campaign for...

That this House welcomes the Diabetes UK campaign Measure Up, which aims to raise awareness of diabetes; recognises that there are currently an estimated 750,000 people in the UK who have diabetes who are not aware of their condition; notes that the campaign aims to identify at least 25 per cent. of these people; further notes the seriousness of diabetes, which if left untreated can lead to blindness, kidney disease, heart attacks and other life-threatening complications; supports the key messages of the campaign that if you are a white or black male and your waist is 37 inches or more, a woman and your waist is 31.5 inches or more, or a South Asian man and your waist is 35 inches or more, you could need a test for diabetes; observes that keeping people with the condition healthier will also reduce the long-term impact on limited NHS resources; expresses its concern over Department of Health figures which show that only 72 per cent. of the diabetic population has been diagnosed across the UK; further notes that some primary care trusts have only diagnosed around half of their diabetic population; and calls on the Government to encourage primary care trusts to spell out their plans for early identification of people with diabetes in their local area.

That this House welcomes the Diabetes UK campaign Measure Up, which aims to raise awareness of diabetes; recognises that there are currently an estimated 750,000 people in the UK who have diabetes who are not aware of their condition; notes that the campaign aims to identify at least 25 per...

That this House notes with concern that 65 per cent. of the two million people in the UK with diabetes are not taking their medications as prescribed because one in three do not understand what those medications are for, or how to take them; welcomes the work of a coalition of Diabetes UK, the Association of the British Pharmaceutical Society and Ask About Medicines to facilitate understanding of medicines used to treat diabetes; believes that everyone with the condition has a right to expect a personalised information prescription expressed in an appropriate format as part of their care planning process; further believes that such a personalised prescription should help to ensure that access to clear and consistent information that is accurate, up-to-date and trustworthy will enable people with diabetes to understand their condition and treatment options regardless of their age, ethnicity, disability or postcode; further believes that people should be encouraged to seek information on medicines and other treatments by discussing their condition with and asking questions of a range of healthcare professionals and by accessing other forms of support and information tailored for each person in their particular situation; and therefore calls on the Government to ensure that the NHS at a local level provides diabetes care and support in line with these standards.

That this House notes with concern that 65 per cent. of the two million people in the UK with diabetes are not taking their medications as prescribed because one in three do not understand what those medications are for, or how to take them; welcomes the work of a coalition...

That this House disagrees with the National Institute for Health and Clinical Excellence's recent technology appraisal document which proposes the restriction of access to inhaled insulin products on the NHS to patients with `a proven injection phobia diagnosed by a psychiatrist or psychologist'; is concerned that diabetes sufferers often delay treatment for as long as four years due to a fear of injections, risking the complications of heart disease, blindness and kidney failure, a situation that will only be compounded by attaching the unfortunate stigma of mental illness to those with a phobia of needles; expresses concern at the additional workload that will be placed on already overstretched NHS psychiatric services; and believes that the judgment of expert clinicians should be trusted in managing each individual patient's condition.

That this House disagrees with the National Institute for Health and Clinical Excellence's recent technology appraisal document which proposes the restriction of access to inhaled insulin products on the NHS to patients with `a proven injection phobia diagnosed by a psychiatrist or psychologist'; is concerned that diabetes sufferers often delay...

That this House supports the International Diabetes Federation's Unite for Diabetes campaign, which aims to highlight the alarming rise of diabetes worldwide; notes with concern new data showing that more than 230 million people have been diagnosed with diabetes and that the number of people living with diabetes is expected to grow to 350 million in less than 20 years if action is not taken; further notes that diabetes is one of the major causes of premature death worldwide, as every 10 seconds a person dies from diabetes-related causes and death rates are predicted to rise by 25 per cent. over the next decade; further notes that World Health Organisation research predicts that the condition could reduce life expectancy globally for the first time in 200 years and that almost six per cent. of the world's adult population now live with diabetes; and encourages Government support for a United Nations Resolution on diabetes, to secure the Resolution on World Diabetes Day on 14th November 2007.

That this House supports the International Diabetes Federation's Unite for Diabetes campaign, which aims to highlight the alarming rise of diabetes worldwide; notes with concern new data showing that more than 230 million people have been diagnosed with diabetes and that the number of people living with diabetes is expected...

That this House welcomes the Diabetes UK's campaign Measure Up, which aims to raise awareness of diabetes; recognises that there are currently an estimated 750,000 people in the UK who have diabetes who are not aware of their condition; notes that the campaign aims to identify at least 25 per cent. of these people; further notes the seriousness of diabetes, which if left untreated can lead to blindness, kidney disease, heart attacks and other life-threatening complications; supports the key messages of the campaign that if you are a white or black male and your waist is 37 inches or more, a woman and your waist is 31.5 inches or more, or a South Asian man and your waist is 35 inches or more, you could need a test for diabetes; observes that keeping people with the condition healthier will also reduce the long-term impact on limited NHS resources; expresses its concern over Department of Health figures which show that only 72 per cent. of the diabetic population have been diagnosed across the UK; further notes that some primary care trusts have only diagnosed around half of their diabetic population; and calls on the Government to encourage primary care trusts to spell out their plans for early identification of people with diabetes in their local area.

That this House welcomes the Diabetes UK's campaign Measure Up, which aims to raise awareness of diabetes; recognises that there are currently an estimated 750,000 people in the UK who have diabetes who are not aware of their condition; notes that the campaign aims to identify at least 25 per...

That this House notes with concern that 65 per cent. of the two million people in the UK with diabetes are not taking their medications as prescribed because one in three do not understand what those medications are for, or how to take them; welcomes the work of a coalition of Diabetes UK, the Association of the British Pharmaceutical Society and Ask About Medicines to facilitate understanding of medicines used to treat diabetes; believes everyone with the condition has a right to expect a personalised information prescription expressed in an appropriate format as part of their care planning process; further believes that such a personalised prescription should help ensure that access to clear and consistent information that is accurate, up-to-date and trustworthy enabling people with diabetes to understand their condition and treatment options regardless of their age, ethnicity, disability or postcode; further believes that people should be encouraged to seek information on medicines and other treatments by discussing their condition with and asking questions of a range of healthcare professionals and by accessing other forms of support and information tailored for each person in their particular situation; and therefore calls on the Government to ensure that the NHS at a local level provides diabetes care and support in line with these standards.

That this House notes with concern that 65 per cent. of the two million people in the UK with diabetes are not taking their medications as prescribed because one in three do not understand what those medications are for, or how to take them; welcomes the work of a coalition...

That this House supports the International Diabetes Federation's Unite for Diabetes campaign, which aims to highlight the alarming rise of diabetes worldwide; notes with concern new data showing that more than 230 million people have been diagnosed with diabetes and that the number of people living with diabetes is expected to grow to 350 million in less than 20 years if action is not taken; further notes that diabetes is one of the major causes of premature death worldwide, as every 10 seconds a person dies from diabetes-related causes and death rates are predicted to rise by 25 per cent. over the next decade; further notes that World Health Organisation research predicts that the condition could reduce life expectancy globally for the first time in 200 years and that almost six per cent. of the world's adult population now live with diabetes; and encourages Government support for a United Nations Resolution on diabetes, to secure the Resolution on World Diabetes Day on 14th November 2007.

That this House supports the International Diabetes Federation's Unite for Diabetes campaign, which aims to highlight the alarming rise of diabetes worldwide; notes with concern new data showing that more than 230 million people have been diagnosed with diabetes and that the number of people living with diabetes is expected...

That this House disagrees with the National Institute for Health and Clinical Excellence's recent technology appraisal document which proposes the restriction of access to inhaled insulin products on the NHS to patients with `a proven injection phobia diagnosed by a psychiatrist or psychologist'; is concerned that diabetes sufferers often delay treatment for as long as four years due to a fear of injections, risking the complications of heart disease, blindness and kidney failure, a situation that will only be compounded by attaching the unfortunate stigma of mental illness to those with a phobia of needles; expresses concern at the additional workload that will be placed on already overstretched NHS psychiatric services; and believes that the judgement of expert clinicians should be trusted in managing each individual patient's condition.

That this House disagrees with the National Institute for Health and Clinical Excellence's recent technology appraisal document which proposes the restriction of access to inhaled insulin products on the NHS to patients with `a proven injection phobia diagnosed by a psychiatrist or psychologist'; is concerned that diabetes sufferers often delay...

That this House welcomes Diabetes Week, taking place between 11th and 17th June; notes with concern that the number of people diagnosed with diabetes in the United Kingdom has already reached 2.1 million and is expected to reach 3 million by 2010, and that diabetes is now in the top five most common non-contagious diseases in the United Kingdom and is one of the main threats to human health in the 21st century; further notes that diabetes deaths are predicted to rise by 25 per cent. over the next decade and that people with diabetes are five times more likely to die from heart failure as those without diabetes; congratulates Diabetes UK for the positive work that the organisation has undertaken to raise awareness of the rising threat of diabetes and associated diseases; and calls on the Government to ensure that the NHS at a local level provides diabetes care and support in line with the standards set out in the National Service Framework for Diabetes.

That this House welcomes Diabetes Week, taking place between 11th and 17th June; notes with concern that the number of people diagnosed with diabetes in the United Kingdom has already reached 2.1 million and is expected to reach 3 million by 2010, and that diabetes is now in the top...

That this House recognises that diabetes is a major cause of ill-health in the UK, affecting more than two million people; notes with concern that the prevalence of diabetes is increasing, particularly among high risk groups such as those who are overweight and those of black or Asian origin; acknowledges that diabetes is a condition largely managed by patients themselves; further notes with concern that the recent Government consultation on the arrangements for the provision of dressings and chemical reagents may lead to a potential reduction of ??19 million in the associated complementary services provided by manufacturers of diabetes testing strips, therefore significantly reducing patients' ability to self-manage their diabetes; and calls on the Government to take urgent steps to reassure patients that any cuts resulting from the consultation will not jeopardise the high quality of diabetes care, products and services currently available.

That this House recognises that diabetes is a major cause of ill-health in the UK, affecting more than two million people; notes with concern that the prevalence of diabetes is increasing, particularly among high risk groups such as those who are overweight and those of black or Asian origin; acknowledges...

That this House expresses its deep concern that the National Institute for Health and Clinical Excellence (NICE) appraisal consultation document (ACD) recommends that new inhaled insulin should not be available to NHS patients with diabetes although diabetes is a major and growing health problem that affects two million people in the UK, and complications arising from poor management of the condition costs the NHS ??5 billion every year; notes that both the Food and Drug Administration and the European Medicines Evaluation Agency granted inhaled insulin a licence based on robust scientific and medical evidence and that it is one of the most significant medical breakthroughs in diabetes treatment since the discovery of insulin in the 1920s; regrets that the UK had the opportunity to be at the forefront of this development in improving diabetic care, and that the NICE ACD means that patients with diabetes in the UK will either have to pay for this new mode of treatment or continue with the daily multiple injections that lie at the heart of so many problems in managing the disease; and calls upon the Government to find ways to ensure that the NHS provides early and free access to inhaled insulin, so that the benefits of this new approach can be realised for patients in the UK.

That this House expresses its deep concern that the National Institute for Health and Clinical Excellence (NICE) appraisal consultation document (ACD) recommends that new inhaled insulin should not be available to NHS patients with diabetes although diabetes is a major and growing health problem that affects two million people in...

That this House notes with concern the study by the University of Leicester which found physical inactivity in increasing numbers of children is putting them at serious risk of developing diabetes; is concerned by the increasing number of children suffering Type-2 diabetes, a condition which was previously thought only to affect those over the age of 40; further notes that at least 36,000 people in the United Kingdom suffer from diabetes, including 1,000 children, and that another 30,000 people may have the condition undiagnosed; and calls on schools and local authorities to encourage children to take part in, and to enjoy, sport and to discourage parents where appropriate from driving their children to school.

That this House notes with concern the study by the University of Leicester which found physical inactivity in increasing numbers of children is putting them at serious risk of developing diabetes; is concerned by the increasing number of children suffering Type-2 diabetes, a condition which was previously thought only to...

That this House welcomes the launch of the Hansard Society report on Wednesday 16th March with the findings of the recent online consultation on diabetes undertaken in partnership with the All-Party Parliamentary Group for Diabetes and Sanofi-Aventis; stresses the significance of the consultation in capturing the experience of 350 people and providing a unique grass-roots debate on diabetes service delivery and attainment of optimal glucose control as measures by a target HbA1c level; and calls on the Government to study the report and take its recommendations on the full implementation of the National Service Framework for Diabetes into consideration.

That this House welcomes the launch of the Hansard Society report on Wednesday 16th March with the findings of the recent online consultation on diabetes undertaken in partnership with the All-Party Parliamentary Group for Diabetes and Sanofi-Aventis; stresses the significance of the consultation in capturing the experience of 350 people...

That this House expresses concern at reports from the Insulin Dependent Diabetes trust that NovoNordisk is threatening to cease production of animal-based insulin products, one of only two current suppliers of such insulin in the UK; acknowledges the reduction of warning symptoms of an impending hypoglycaemic attack experienced by some diabetics who were switched from animal based to synthetic human insulins; notes the importance of providing easy and consistent access to both types of insulin; and calls on the Government to ensure a reliable supply of animal insulin is secured for the foreseeable future.

That this House expresses concern at reports from the Insulin Dependent Diabetes trust that NovoNordisk is threatening to cease production of animal-based insulin products, one of only two current suppliers of such insulin in the UK; acknowledges the reduction of warning symptoms of an impending hypoglycaemic attack experienced by some...

That this House believes a significant lack of education is allowing healthcare professionals and patients alike to become confused as to the best and most effective use of blood glucose monitoring for diabetes and that because the current primary care trust guidelines discourage the prescription of blood glucose strips for self-monitoring, it may become difficult for those in primary care to meet the National Institute for Clinical Excellence-recommended blood glucose target levels; and calls on Her Majesty's Government to ensure that blood glucose monitoring strips are not restricted for type II diabetes patients who are best placed to self-manage their condition.

That this House believes a significant lack of education is allowing healthcare professionals and patients alike to become confused as to the best and most effective use of blood glucose monitoring for diabetes and that because the current primary care trust guidelines discourage the prescription of blood glucose strips for...